New approaches in the treatment of hepatitis C

doi:10.3748/wjg.v22.i4.1421

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15214)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

1492

WORD

368

HTML

9495

Tables (1-4)

121

Sum=11476

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

362

Download

698

Sum=1060

Publishing Process of This Article

Item

Count

Browse

1197

Download

1481

Sum=2678

Jan 28, 2016 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (102)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 28, 2016; 22(4): 1421-1432
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1421

Table 3 Recommedation for therapy in patients with genotypes 2 and 3

Patient characterization	Recommended	Duration (wk)	Scientific evidence
Genotype 2 naive noncirrhotic/cirrhotic	SOF + RBV	12	Fission positron
Genotype 2 naive noncirrhotic/cirrhotic	SOF + PEG + RBV	12	Lonestar-2
Genotype 2 retretated noncirrhotic	SOF + RBV	12	Fussion valence
Genotype 2 retretated noncirrhotic	SOF + PEG + RBV	12	Lonestar-2
Genotype 2 retreated cirrhotic	SOF + PEG + RBV	12	Lonestar-2
Genotype 2 retreated cirrhotic	SOF + RBV	16	Fussion valence
Genotype 3 naive and retreated noncirrhotic/cirrhotic	SOF + RBV	24	Valence
	SOF + PEG + RBV	12	Lonestar-2
	SOF + LDV + RBV	12	Electron-2
	SOF + DVC (No en cirróticos)	12	Ally-3

Citation: González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22(4): 1421-1432
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1421.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1421